Adverum Biotechnologies Inc Live Stock Price Today, Share Analysis and Chart

Name: Adverum Biotechnologies Inc: Is Infosys Ltd. worth buying?
Item: Adverum Biotechnologies Inc
Rating: 1.47466675
Author: Trendlyne DVM scores

about

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustaine...

3.02 0.05 (1.68%)

64.72% Fall from 52W High

71,753

XNAS Volume

XNAS 25 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.2 / 100

Technically Neutral

47.8 / 100

1Yr Price target upside is 546%

4 analysts

Adverum Biotechnologies Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adverum Biotechnologies Inc Live Stock Price Today, Share Analysis and Chart

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustaine...

64.72% Fall from 52W High

SWOT Analysis

Adverum Biotechnologies Inc Live Price Chart